Login to Your Account



Amgen Reports Phase II Data On Epratuzumab, Pegfilgrastim


Wednesday, December 12, 2001
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription